The clinical study of the dual-route administration with recombinant human endostatin plus gemcitabine and cisplatin regimen on advanced non-small cell lung cancer

XU Jian; CHEN Bo; CAO Jian-min; JIA Shao-chang; HU Xiao-bo; ZHANG Long-jiang; LU Guang-ming

doi:10.3969/j.issn.1009-0460.2011.08.010

Home>Articles>The clinical study of the dual-route administration with recombinant human endostatin plus gemcitabine and cisplatin regimen on advanced non-small cell lung cancer

DOI: 10.3969/j.issn.1009-0460.2011.08.010

The clinical study of the dual-route administration with recombinant human endostatin plus gemcitabine and cisplatin regimen on advanced non-small cell lung cancer

XU Jian

CHEN Bo

CAO Jian-min

JIA Shao-chang

HU Xiao-bo

ZHANG Long-jiang

LU Guang-ming

Machine-generated Keywords：

Publication Date：2011-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：6( 709-714 )

Chinese Clinical Oncology

PKUISTIC

ISSN：1009-0460

Year, Vol.(Issue)：2011,16(8)